Skip to main content
WLYJohn Wiley & Sons, Inc.Hold6.3·$49.40-0.80%
WLY · Concentration risk · 10-K extracted

John Wiley & Sons (WLY) concentration risks

Updated

The most significant concentration John Wiley & Sons discloses is Research segment at 64%, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Source: John Wiley & Sons’s SEC Form 10-K filed view the filing on SEC EDGAR ↗

At a glance

Disclosed-size breakdown · 5 disclosed concentrations

HIGH2
MEDIUM3
LOW0
Disclosed concentrations

Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).

HIGHBuilt-inProduct / Revenue mix
64%

Research segment

10-K Item 1: 'Research revenue accounted for approximately 64% of our consolidated revenue in the year ended April 30, 2025'
SEC 10-K · filed Jun 2025
HIGHOutside partyCounterparty

Cengage Learning

10-K Item 1: 'We have an agreement to outsource our US-based book distribution operations to Cengage Learning'
SEC 10-K · filed Jun 2025
MEDIUMBuilt-inGeographic
49%

outside the United States

10-K Item 1: 'approximately 49% of our consolidated revenue was from outside the US'
SEC 10-K · filed Jun 2025
MEDIUMOutside partyCounterparty
46%

professional societies and publishing partners

10-K Item 1: 'Approximately 46% of Journal Subscriptions revenue is derived from publication rights that are owned by professional societies and other publishing partners such as research institutions or foundations'
SEC 10-K · filed Jun 2025
MEDIUMBuilt-inProduct / Revenue mix
35%

Learning segment

10-K Item 1: 'Learning accounted for approximately 35% of our consolidated revenue in the year ended April 30, 2025'
SEC 10-K · filed Jun 2025
TrendMatrix Research · concentration synthesis

What these concentrations mean together

updated 2026-07-06

Wiley's concentration risk mixes segment structure with real counterparty dependency, split across high- and medium-share bands. The Research segment is the core of the business, accounting for approximately 64% of consolidated revenue in the year ended April 30, 2025 — a high-share structural exposure to that one segment's dynamics. Layered on top is a high-share dependency: US-based book distribution operations are outsourced to a single named counterparty, Cengage Learning, concentrating an operational function in one relationship rather than spreading it across vendors. The remaining exposures sit at medium-share. Roughly 49% of consolidated revenue came from outside the United States, a structural geographic exposure to international conditions. Within Research specifically, approximately 46% of Journal Subscriptions revenue derives from publication rights owned by professional societies and other publishing partners — a medium-share dependency on external rights-holders rather than Wiley's own content. The Learning segment contributed approximately 35% of consolidated revenue, the smaller of the two reporting segments. Together, these describe a company whose largest segment itself depends partly on externally-owned publishing rights, whose international revenue is a substantial minority, and whose US distribution runs through a single outsourced partner — dependency risk compounds structural segment concentration rather than sitting apart from it.

For the engine’s reasoning on WLY’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Industry peers · Publishing

Peer concentration profile

SymbolNameHIGHMEDIUMLOWTotal
WLYJohn Wiley & Sons, Inc.2305
WLYBJohn Wiley & Sons, Inc.2305
TDAYUSA TODAY Co., Inc.1102
NYTNew York Times Company (The)0101
SCHLScholastic Corporation0000

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.

Concentration disclosures are extracted verbatim from SEC 10-K filings; the disclosed-size classification and the synthesis above are engine-derived. Size reflects how large each exposure is against fixed share thresholds (HIGH >50%, MEDIUM 25–50%, LOW <25% or an explicit diversification statement), not a judgment of how dangerous it is, and is not a buy/sell rating, a price target, or a view on the stock. Not a complete list of risk factors — see the full filing.

Home Stocks WLY Concentration risk